HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mayumi Yoshioka Selected Research

Trefoil Factors

12/2021Diet Impact on Obesity beyond Calories and Trefoil Factor Family 2 (TFF2) as an Illustration: Metabolic Implications and Potential Applications.
8/2021Trefoil Factor Family Member 2: From a High-Fat-Induced Gene to a Potential Obesity Therapy Target.
1/2021High-Fat Diet-Induced Trefoil Factor Family Member 2 (TFF2) to Counteract the Immune-Mediated Damage in Mice.
1/2021Trefoil Factor Family Member 2 Expression as an Indicator of the Severity of the High-Fat Diet-Induced Obesity.
12/2018Energy and metabolic pathways in trefoil factor family member 2 (Tff2) KO mice beyond the protection from high-fat diet-induced obesity.
7/2013Trefoil factor family member 2 (Tff2) KO mice are protected from high-fat diet-induced obesity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mayumi Yoshioka Research Topics

Disease

16Obesity
12/2021 - 06/2005
4Inflammation (Inflammations)
01/2021 - 01/2020
3Neoplasms (Cancer)
01/2021 - 02/2008
3Sarcopenia
01/2020 - 10/2010
2Labyrinth Diseases
08/2009 - 02/2009
2Prostatic Neoplasms (Prostate Cancer)
02/2009 - 02/2008
1Muscular Atrophy (Muscle Atrophy)
01/2022
1Weight Loss (Weight Reduction)
10/2021
1COVID-19
10/2021
1Wounds and Injuries (Trauma)
01/2021
1Burns
12/2020
1Leukemia
12/2020
1Mitochondrial Diseases (Mitochondrial Disease)
01/2020
1Brain Diseases (Brain Disorder)
01/2011
1Carotid Artery Diseases
10/2010
1Arteriolosclerosis
10/2010
1Abdominal Obesity
10/2010
1Sensorineural Hearing Loss
08/2009
1Meniere Disease (Menieres Disease)
08/2009
1Endolymphatic Hydrops
02/2009
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2009
1Insulin Resistance
01/2009
1Hypertension (High Blood Pressure)
01/2009
1Hearing Loss (Hearing Impairment)
05/2008

Drug/Important Bio-Agent (IBA)

6Trefoil FactorsIBA
12/2021 - 07/2013
4Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2020
4Cysteine (L-Cysteine)FDA Link
01/2022 - 01/2020
4Hormones (Hormone)IBA
01/2020 - 01/2009
3Biological ProductsIBA
10/2021 - 12/2020
3LipidsIBA
08/2021 - 12/2018
3Pharmaceutical PreparationsIBA
01/2020 - 08/2009
2AndrogensIBA
10/2010 - 02/2009
1Histones (Histone)IBA
11/2021
1VaccinesIBA
10/2021
1AntibodiesIBA
10/2021
1CollagenIBA
01/2021
1Indicators and Reagents (Reagents)IBA
01/2021
1DNA (Deoxyribonucleic Acid)IBA
12/2020
1Glucose (Dextrose)FDA LinkGeneric
12/2018
1OrexinsIBA
01/2011
1Retinaldehyde (Retinal)IBA
10/2010
1Gentamicins (Gentamicin)FDA LinkGeneric
08/2009
1SteroidsIBA
08/2009
1Adenosylmethionine DecarboxylaseIBA
02/2009
1GadoliniumIBA
02/2009
1MineralocorticoidsIBA
01/2009
1GlucocorticoidsIBA
01/2009
1Small Interfering RNA (siRNA)IBA
02/2008
1Estrogens (Estrogen)FDA Link
06/2005

Therapy/Procedure

12Therapeutics
01/2022 - 06/2005
1Obesity Management
11/2021
1Radiotherapy
12/2020
1Precision Medicine
12/2020
1Drug Therapy (Chemotherapy)
02/2009
1Hearing Aids (Hearing Aid)
05/2008